GE HealthCare Technologies Non-GAAP EPS of $1.34 beats by $0.14, revenue of $5.51B beats b
GE HealthCare Technologies reported Q3 Non-GAAP EPS of $1.34, exceeding estimates by $0.14, with revenue of $5.51B, up 7.2% Y/Y and beating by $160M. The company also raised its FY guidance. According to GEHC, organic orders grew 4.0%, with a book-to-bill ratio of 1.03 and a backlog of $23.7B.
How this was made
The 30-second read
Why it matters
The earnings beat and raised guidance are likely to trigger short‑term buying, supporting the stock price in early trading.
Market read
First‑report earnings with material beat for a large‑cap health‑care firm; high relevance for traders.
What to watch
Potential headwinds from supply‑chain constraints and regulatory scrutiny in key markets.
Background
GE HealthCare Technologies released its Q3 earnings via a press release on Oct 28, 2026.
Ticker impact
Q3 Non‑GAAP EPS of $1.34 beats consensus by $0.14 and revenue of $5.51B beats by $160M, with FY guidance raised.
upward pressure as the market prices in the earnings beat and guidance raise
Large‑cap health‑care stock with material beat; investors typically react positively to both EPS and revenue surprises and guidance upgrades.
Market effects
May lift broader health‑care equipment and services sector on earnings optimism.
Positive for U.S. large‑cap stocks, especially in the medical technology space.
Limited to investors tracking U.S. health‑care equities.
Counterpoint
Some analysts may caution that the beat is modest and future growth could be constrained by macro‑economic pressures.
Key entities
- CompanyGE HealthCare Technologies Inc.
U.S. listed health‑care equipment and services provider.
